Inhibition of lipopolysaccharide-induced inflammation by trophoblast-conditioned medium and trophoblast-derived extracellular vesicles in human middle ear epithelial cells

Sci Rep. 2023 Nov 14;13(1):19822. doi: 10.1038/s41598-023-46731-7.

Abstract

Otitis media is a common disease but can cause severe inner ear inflammation and hearing loss if it persists for more than two weeks. This study elucidates the inflammation-inhibiting efficacy of conditioned medium (CM) and extracellular vesicles (EVs) derived from human trophoblast (TB) cells in lipopolysaccharide (LPS)-induced human middle ear epithelial cells (HMEECs). TB-conditioned medium (TB-CM) reduced the inflammatory response and regulated mucin and epithelial sodium channel genes in LPS-induced HMEECs. The underlying mechanism of cell migration during inflammatory healing in LPS-induced HMEECs treated with TB-CM was determined by RNA-sequencing analysis. Specifically, the NF-κB pathway related to the copper metabolism MURR1 domain protein was studied and verified through siRNA. This elucidation of the anti-inflammatory effect of TB-CM and TB-derived EVs demonstrates their clinical potential to treat chronic inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Culture Media, Conditioned / metabolism
  • Culture Media, Conditioned / pharmacology
  • Ear, Middle
  • Epithelial Cells / metabolism
  • Extracellular Vesicles*
  • Humans
  • Inflammation / chemically induced
  • Inflammation / metabolism
  • Lipopolysaccharides* / pharmacology
  • Trophoblasts

Substances

  • Lipopolysaccharides
  • Culture Media, Conditioned